logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sarepta Pharmaceuticals Jumps on Competitor’s Failure

  +Follow August 16, 2013 9:54AM
Share:
Tickers Mentioned:

Sarepta Therapeutics Inc. (SRPT) experienced a bit of schadenfreude on Aug. 16 as a direct competitor stumbled badly at the finish line.

Competitor GlaxoSmithKline plc (GSK) had been neck-and-neck with Serepta in the race to develop a breakthrough muscle disorder drug to treat Duchenne Muscular Dystrophy. Both drugs were far ahead of the pack in the development process.

That is, until Baird analyst Brian Skorney reported that Glaxo’s drug, drisapersen, has encountered major stumbling blocks on several fronts that could significantly hamper development. Skorney cited clinical, regulatory, and commercials issues with the drug. Most importantly, the drug did not seem to effectively treat symptoms of the disease at the targeted dose.

Serepta’s drug, eteplirsen, so far has seemed to be effective at treating symptoms of Duchenne. Clinical trials have taken place in the UK. On Aug. 7 the company released promising clinical trial information, which will form the basis of their application for US FDA approval in early 2014.

Duchenne is a severely debilitating form of muscular dystrophy. The recessive muscular degenerative disorder affects approximately 1 in 3,600 boys, and life expectancy for sufferers is usually around 25. A drug from either company would be the first on the American market designed to treat the disorder.

The London-based GlaxoSmithKline , which is the fourth largest pharmaceutical company in the world, shrugged off the setback. Their stock is up .33 percent to hit $51.70 a share.

Serepta is up 6.77 percent to hit $34.21 a share.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Signup for our daily newsletter and get our best articles emailed right to you!

Results for GSK
avidresearch
2 Sep 14 17:09:47
RT @psuvafan007: $GSK investors call for chairman's head after sorry Q2, bribery probes http://t.co/c0hOPq3lMY #abouttime
Dr. Zoidberg
2 Sep 14 15:54:47
$GSK investors call for chairman's head after sorry Q2, bribery probes http://t.co/c0hOPq3lMY #abouttime
Market News
2 Sep 14 14:23:14
$GSK: Use caution when investing in Ebola-related stocks http://t.co/GFpoBXTFXD http://t.co/Ab0WCeWXMR
FOREX Insight
2 Sep 14 13:56:29
RT @SeekingAlpha: 8 Global Dividend Dogs Stalk 11% To 66% August Upsides http://t.co/Mwe7bbfM1L $APSA $BCE $BP $BSMX $CIG $E $EC $FLY $GSK …
Evener Investment
2 Sep 14 13:54:46
RT @SeekingAlpha: 8 Global Dividend Dogs Stalk 11% To 66% August Upsides http://t.co/Mwe7bbfM1L $APSA $BCE $BP $BSMX $CIG $E $EC $FLY $GSK …
Seeking Alpha
2 Sep 14 13:49:42
8 Global Dividend Dogs Stalk 11% To 66% August Upsides http://t.co/Mwe7bbfM1L $APSA $BCE $BP $BSMX $CIG $E $EC $FLY $GSK $IRS $NPD $ORAN
12Stocks.com Biotech
2 Sep 14 13:48:17
Glaxo Up on Accelerated Ebola Vaccine Development Process.. http://t.co/Cg8Lb3nvYZ $GSK #biotech #stocks
Stock Market Monitor
2 Sep 14 13:23:07
$GSK: The Benefits Of Investing In GlaxoSmithKline plc http://t.co/wbC1mclFZp http://t.co/geHLF30Jfo
Stock Rocket
2 Sep 14 13:19:54
$DGLY is up 940.2% in 3 weeks! Our new penny stock alerts are coming soon: http://t.co/G4xan5kQD5 $LFAP $GSK $ROX
ChoZyn
2 Sep 14 13:17:12
So we start Ebola trials and no one post any news...hmmm Awkward $GSK $TKMR
Bidness Etc
2 Sep 14 13:02:49
Cipla Poses Strong Competition For GSK And Gilead http://t.co/I5GABhYyzX $GSK $GILD $MYL
TrendCache
2 Sep 14 12:30:24
#Trending #Biotech topics include $GSK, $ALDR, $KWU14.CBT #stocks #invest See more http://t.co/0Uk8oXnazd
Mike Watson Frick
2 Sep 14 12:01:59
$GSK commits to freezing #vaccine prices for 5 years for countries graduating from @GaviAlliance support http://t.co/f8C5pBYDpr
Jack Trader
2 Sep 14 12:01:19
$GSK Cipla Poses Strong Competition For GSK And Gilead http://t.co/SnjVZTsqL8
James P Worthy
2 Sep 14 12:01:18
$GSK GlaxoSmithKline plc (ADR) (NYSE:GSK) and NIH Spearheading Development of ... http://t.co/pgG7I9YZYU
WallStreet
2 Sep 14 10:24:52
$GSK - GlaxoSmithKline plc (ADR) (NYSE:GSK) and NIH Spearheading Development of Ebola Vaccine - http://t.co/uoQBxZlFrr
Nigam Arora
2 Sep 14 09:43:58
USE CAUTION WHEN INVESTING IN EBOLA-RELATED STOCKS $TKMR $ITMN $GSK $BCRX $NLNK http://t.co/sOhQJEaxXA
Market News
2 Sep 14 09:23:15
$GSK: [video] Jim Cramer Says Roche's "Bolt-On" Acquisition Means Big Pharma is Thinking Big http://t.co/vdthrTJoQG http://t.co/e47BvoLLrg
Tinnitus Helps
2 Sep 14 09:21:05
RT @FiercePharma: Cipla's Advair copy gathers steam with rollouts in Germany, Sweden http://t.co/YkXC2Tb2zu $GSK #pharma by @CarlyHFierce
FiercePharma
2 Sep 14 09:20:11
Cipla's Advair copy gathers steam with rollouts in Germany, Sweden http://t.co/YkXC2Tb2zu $GSK #pharma by @CarlyHFierce
Fabrice Vezin
2 Sep 14 09:17:13
RT @FiercePharma: GSK investors call for chairman's head after sorry Q2, bribery probes http://t.co/lTCQv0BRME $GSK #pharma by @TracyStaton
Murphy IP Law
2 Sep 14 09:07:57
RT @FiercePharma: GSK investors call for chairman's head after sorry Q2, bribery probes http://t.co/lTCQv0BRME $GSK #pharma by @TracyStaton
Carly Helfand
2 Sep 14 09:01:15
Cipla's Advair copy gathers steam with rollouts in Germany, Sweden: http://t.co/nReIyf7ZkG $GSK #pharma
FQ_Toxicity
2 Sep 14 08:59:10
RT @FiercePharma: GSK investors call for chairman's head after sorry Q2, bribery probes http://t.co/lTCQv0BRME $GSK #pharma by @TracyStaton
FiercePharma
2 Sep 14 08:58:49
GSK investors call for chairman's head after sorry Q2, bribery probes http://t.co/lTCQv0BRME $GSK #pharma by @TracyStaton
Context Matters
2 Sep 14 08:32:03
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
StockNews
2 Sep 14 08:31:13
$GSK - Report of Foreign Issuer (6-k) http://t.co/UBCuOVk8G9
janet gale
2 Sep 14 07:52:08
$GSK - GlaxoSmithKline PLC Director/PDMR Shareholding http://t.co/wbEBdkR1SL
Florida Biotech
2 Sep 14 07:22:04
RT @Stocks_Biotech: My Favourite 5%+ Yields: GlaxoSmithKline plc, Centrica PLC & Vodafone Group plc.. http://t.co/cehl1XyndH $GSK #biotech …
Jean-Pierre Trudel
2 Sep 14 06:14:05
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
Luis Daniel
2 Sep 14 06:12:38
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
WSJ Health News
2 Sep 14 06:05:17
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
Stefanie Ilgenfritz
2 Sep 14 06:05:17
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
Scott Strumello
2 Sep 14 06:00:49
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
Biotech Investor
2 Sep 14 05:52:43
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
Diet & Nutrition
2 Sep 14 05:47:25
RT @pharmalot: Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
pharmalot
2 Sep 14 05:43:51
Pharmalot.. Pharmalittle.. Good Morning.. welcome back.. http://t.co/FN67XqWedM #pharma $NOVO $GSK $EXEL $MRK $NVS $AZN
12Stocks.com Biotech
2 Sep 14 05:37:02
My Favourite 5%+ Yields: GlaxoSmithKline plc, Centrica PLC & Vodafone Group plc.. http://t.co/cehl1XyndH $GSK #biotech #stocks
Business Headlines
2 Sep 14 05:23:16
$GSK: The Benefits Of Investing In GlaxoSmithKline plc http://t.co/vWD4KZbT6m http://t.co/9fcnz9FNQF
tmerrill
2 Sep 14 05:14:27
RT @fwpharma: ICYMI: Cipla launches #generic version of GlaxoSmithKline's Advair in Germany, Sweden http://t.co/hxGFtvq94R $GSK #pharma
FirstWord Pharma
2 Sep 14 05:00:08
ICYMI: Cipla launches #generic version of GlaxoSmithKline's Advair in Germany, Sweden http://t.co/hxGFtvq94R $GSK #pharma
ARK Genome
2 Sep 14 04:29:32
1st human trial for an #Ebola vaccine will begin this week. $GSK has the honors. http://t.co/gVwMpVtJ2c
Perfor Mance
2 Sep 14 04:12:14
Option Millionaires: nlightn: $GSK,...Ebola Vaccine: First-Ever Human Trials For Experimental Drug http://t.co/BtSiUGg8Gl
strader55
2 Sep 14 04:05:46
nlightn: $GSK,...Ebola Vaccine: First-Ever Human Trials For Experimental Drug http://t.co/iMgg3HmZBr
StockNews
2 Sep 14 03:40:08
$GSK - Report of Foreign Issuer (6-k) http://t.co/TwqE5KSCnI
CDR Life Sciences
2 Sep 14 01:45:40
#Prosonix’ MAA for PSX1001 (generic $GSK Flixotide Evohaler) under assessment in EU http://t.co/nqZguqEdfs #respiratorydrugs
Business Headlines
2 Sep 14 01:22:59
$GSK: My Favourite 5%+ Yields: GlaxoSmithKline plc, Centrica PLC & Vodafone Group plc http://t.co/k172BC6ND8 http://t.co/mOGRQmeLp3
Halifax ShareDealing
2 Sep 14 01:07:40
Yesterday's top #FTSE100 fallers - Morrisons $MRW, Mondi $MNDI, Tesco $TSCO, Shire $SHP and GlaxoSmithKline $GSK
4-traders.com
1 Sep 14 23:40:17
Ligand Pharmaceuticals : FDA to OK GlaxoSmithKline Promacta/Revolade http://t.co/stKbr8pzdc $LGND $GSK
Lance Fiasconaro
1 Sep 14 22:18:33
Stalwart Index Adds: $ABB, $ABT, $BP, $GSK, $KO, $MDLZ, $NVO, $UN #stocks
				
				
  +Follow August 16, 2013 9:54AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.